|
Collegium Pharmaceutical inc (NASDAQ: COLL) |
|
Collegium Pharmaceutical inc
COLL's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Collegium Pharmaceutical Inc growth rates, revenue grew
by 22.75 % in the first quarter of 2025 from the same quarter a year ago.
Ranking at No. 1449
Major Pharmaceutical Preparations industry recorded
growth of revenues by 4.43 %
Collegium Pharmaceutical Inc 's net profit decreased by -91.28 % in first quarter of 2025 year on year, to $2 millions.
• More on COLL's Growth
|
|
Collegium Pharmaceutical Inc current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.
Collegium Pharmaceutical Inc realized cash reduction of $ -3.43 per share in trailing twelve-month period. |
Company |
24.84 |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 1.95.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.32.
• More on COLL's Valuation
|
|
|
|
|
Collegium Pharmaceutical Inc current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.
Collegium Pharmaceutical Inc realized cash outflow of $ -3.43per share in trailing twelve-month period. |
Company |
24.84 |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 1.95.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.32.
Collegium Pharmaceutical Inc Price to Book Ratio is at 4.15 lower than Industry Avg. of 34.08. and higher than S&P 500 Avg. of 0.01
• More on COLL's Valuation
|
|
COLL's Profitability Comparisons
|
Collegium Pharmaceutical Inc faced margin deterioration, primarily through cost pressure. Operating Margin fell in first quarter of 2025 to 12.23 % from 220.45 % in IV. Quarter.
Collegium Pharmaceutical Inc net profit margin of 1.36 % is currently ranking no. 57 in Major Pharmaceutical Preparations industry, ranking no. 168 in Healthcare sector and number 2051 in S&P 500.
Profitability by Segment |
Segment |
1.36 % |
Total |
1.36 % |
|
|
Collegium Pharmaceutical Inc faced margin deterioration, primarily through cost pressure. Operating Margin fell in first quarter of 2025 to 12.23 % from 220.45 % in IV. Quarter.
Collegium Pharmaceutical Inc net profit margin of 1.36 % is currently ranking no. 57 in Major Pharmaceutical Preparations industry, ranking no. 168 in Healthcare sector and number 2051 in S&P 500.
• More on COLL's Key Ratios
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com